The research confirms that the technique can accurately detect people with the neurodegenerative disease and suggests it can identify at-risk individuals
A technique that identifies the build-up of abnormal protein deposits linked to Parkinson's disease could aid in early detection and play a key role in the clinical diagnosis and characterisation of the disorder, according to a study published in The Lancet Neurology journal.
The research confirms that the technique—known as α-synuclein seed amplification assay (αSyn-SAA)—can accurately detect people with the neurodegenerative disease and suggests it can identify at-risk individuals and those with early, non-motor symptoms prior to diagnosis.
No comments:
Post a Comment